Rights and permissions
About this article
Cite this article
HOW VALUABLE IS ISONIAZID IN PATIENTS WITH PULMONARY FIBROTIC LESIONS?. Inpharma Wkly. 396, 2–3 (1983). https://doi.org/10.1007/BF03303628
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03303628